ACTH and β-endorphin in transcendental meditation

Physiology and Behavior

Volumn 64, Issue 3, 1998, Pages 311-315

  Infante, Jose Rafael ^a   Peran, Fernando ^a   Martinez, Margarita ^a   Roldan, Ana ^a   Poyatos, Rafael ^a   Ruiz, Concha ^a   Samaniego, Francisco ^a   Garrido, Federico ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

ACTH; Circadian rhythms; Cortisol; Neuroendocrine axis; Stress modulation; Transcendental Meditation; Endorphin

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN; HYDROCORTISONE;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TRANSCENDENTAL MEDITATION; VOLUNTEER;

EID: 0032098528     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(98)00071-7     Document Type: Article

References (27)

1. Bermudez J. An‡lisis funcional de la ansiedad. Rev. Psicol. Gral. Apl. 153:1978;617-634.
2. Bevan A.J. Endocrine changes in transcendental meditation. Clin. Exp. Pharmacol. Physiol. 7:1980;75-76.
3. Boyer R.M., Witkin M., Carruth A., Ramsey J. Circadian cortisol rhythms in Cushing's disease. J. Clin. Endocrinol. Metab. 48:1979;760-765.
4. Claustrat B., Chazot G., Brun J., Jordan D., Sassolas G. A chronobiological study of melatonin and cortisol secretion in depressed subjects: Plasma melatonin, a biochemical marker in major depression. Biol. Psychiatry. 19:1984;1215-1228.
5. Coeck C., Jorens P.G., Vandevivere J., Mahler C. ACTH and cortisol levels during residency training. N. Engl. J. Med. 325:1991;738.
6. Dillbeck M.C., Bronson E.C. Short-term longitudinal effect of the Transcendental Meditation technique on EEG power and coherence. Int. J. Neurosci. 14:1981;147-151.
7. Elias A.N., Wilson A.F. Serum hormonal concentrations after transcendental meditation - potential role of gamma aminobutyric acid. Med-Hypotheses. 44:1995;287-291.
8. Eppley K., Abrams A., Shear J. Differential effects of relaxation techniques on trait anxiety: A meta-analysis. J. Clin. Psychol. 45:1989;957-974.
9. Facchinetti F., Giovannini G., Barletta C., Petraglia F., Buzzetti R., Burla F., Lazzari R., Genazzani A.R., Scavo D. Hyperendorphinemia in obesity and relationships to affective state. Physiol. Behav. 36:1986;937-940.
10. Gaylord C., Orme-Johnson D., Travis F. The effects of the transcendental meditation technique and progressive muscle relaxation on EEG coherence, stress reactivity, and mental health in black adults. Int. J. Neurosci. 46:1989;77-86.
11. Glaser J.L., Brind J., Vogelman J.H., Eisner M.U., Dillbeck M.C., Wallace R.K., Chopra D., Orentreich N. Elevated serum dehydroepiandrosterone sulfate levels in practitioners of the transcendental meditation (TM) and TM-Sidhi programs. J. Behav. Med. 15:1992;327-341.
12. Jevning R., Wallace R.K., Beidebach M. The physiology of meditation: A review. A wakeful hypometabolic integrated response. Neurosci. Biobehav. Rev. 16:1992;415-424.
13. Jevning R., Wells I., Wilson A.F., Guich S. Plasma thyroid hormones, thyroid stimulating hormone, and insulin during acute hypometabolic states in man. Physiol. Behav. 40:1987;603-606.
14. Jimenez A., Cervera P., Bacardi M. Tabla de composicion de alimentos. 1990;Lab Wander.
15. MacLean C.R., Walton K.G., Wenneberg S.R., Levitsky D.K., Mandarino J.V., Waziri R., Schneider R.K. Altered responses of cortisol, GH, TSH and testosterone to acute stress after four months' practice of transcendental meditation (TM). Ann. N Y Acad. Sci. 746:1994;381-384.
16. Olson G., Olson R., Kastin K. Endogenous Opiates: 1991. Peptides. 13:1992;1247-1287.
17. Orme-Johnson D.W. Medical care utilization and the Transcendental Meditation program. Psychosom. Med. 49:1987;493-507.
18. Reader S.C., Alaghband-Zadeh J., Daly J.R., Robertson W.R. Negative, rate-sensitive feedback effects on adrenocorticotropin secretion by cortisol in normal subjects. J. Endocrinol. 92:1982;443-448.
19. Rivier C., Vale W. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature. 305:1983;325-327.
20. Schneider R.H., Mills P.J., Schramm W., Wallace R.K. Luteinizing hormone: A marker for type a behavior and its modification by the Transcendental Meditation program. Psychosom. Med. 49:1987;212-213.
21. Schneider R.H., Staggers F., Alexander C.N., Sheppard W., Rainforth M., Kondwani K., Smith S., King C.G. A randomised controlled trial of stress reduction for hypertension in older African Americans. Hypertension. 26:1995;820-827.
22. Spielberger C.D., Gorsuch R.L., Lushene R.E. STAI Manual for the State-Trait Anxiety Inventory (Self-Evaluation Questionnaire). 1970;Consulting Psychologists Press, Palo Alto, California.
23. Tietz N.W. Clinical guide to laboratory tests. 1990;W.B. Saunders Co, Philadelphia.
24. Urraca, S. Actitudes ante la muerte (preocupacion, ansiedad, temor) y religiosidad. Madrid: Universidad Complutense; 1981 (Thesis).
25. Wallace R.K. The Maharishi technology of the unified field The neurophysiology of enlightenment . 1986;MIU Neuroscience Press, Fairfield, Iowa.
26. Walton, K. G.; Lerom, M.; Salerno, J.;. Wallace, R. K. Practice of the transcendental meditation (TM) and TM-Sidhi program may affect the circadian rhythm of urinary 5-hydroxyindole excretion. Soc. Neuro. Abstr. 7:48; 1981.
27. Werner O.R., Wallace R.K., Charles B., Janssen G., Stryker T., Chalmers R.A. Long-term endocrinologic changes in subjects practicising the transcendental meditation and TM-Sidhi program. Psychosom. Med. 48:1986;59-66.